Early Rash Development May Signal Superior Benefit With Lapatinib

$ 29.99

4.5 (192) In stock

Early development of rash identified patients with HER2-positive early breast cancer who received superior benefit from lapatinib-based therapy.

Lapatinib: An Oral Dual Tyrosine Kinase Inhibitor for HER-2-Positive Breast Cancer

PDF) Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population

The Rapidly Changing Treatment Landscape of Systemic Therapy for HER-2 Positive Metastatic Breast Cancer

Update on systemic treatment for newly diagnosed inflammatory breast cancer - ScienceDirect

Lapatinib: An Oral Dual Tyrosine Kinase Inhibitor for HER-2-Positive Breast Cancer

Lapatinib

PDF) Lapatinib and lapatinib plus trastuzumab therapy versus

Prognostic value of early rash in all lapatinib-containing treatment arms*

Cancers, Free Full-Text

Related products

How long should I wait for a rash to go away on its own before I

Breastfeeding and rashes on breasts: Understanding the causes and

How To Detect Breast Cancer That Looks Like A Rash: Doctor

CoppaFeel! on X: Inflammatory breast cancer is a rare type of breast cancer which may cause the skin on the breast to look red or inflamed. The symptoms are caused by cancer

My breast implants made me suffer for years with mystery illness that made me go blind